Erdogan Murat Faik, Gursoy Alptekin
Ankara University, School of Medicine, Department of Endocrinology and Metabolic Diseases, Ankara, Turkey.
Pediatr Endocrinol Rev. 2006 Aug;3 Suppl 3:503-7.
Multiple endocrine neoplasia type 2 (MEN 2) is a rare autosomal dominantly inherited familial cancer syndrome caused by mutations in the ret proto-oncogene. MEN 2 has three distinct subtypes, which are MEN 2A, MEN 2B and familial medullary thyroid carcinoma. Identification of a disease gene has enabled a DNA-based strategy for detection of direct mutation in patients with MEN 2 syndromes and in patients with sporadic medullary thyroid carcinoma. The identification of mutations responsible for MEN 2 syndromes has resulted in the routine identification of gene carriers early in life before the development of disease, causing timely prophylactic thyroidectomy in these patients. This report includes our clinical and molecular experience on Turkish MEN 2 families and patients with sporadic medullary thyroid carcinoma diagnosed and treated between 1994 and 2005.
2型多发性内分泌腺瘤病(MEN 2)是一种罕见的常染色体显性遗传家族性癌症综合征,由原癌基因ret的突变引起。MEN 2有三种不同的亚型,即MEN 2A、MEN 2B和家族性甲状腺髓样癌。疾病基因的鉴定使得基于DNA的策略可用于检测MEN 2综合征患者和散发性甲状腺髓样癌患者的直接突变。导致MEN 2综合征的突变的鉴定已使得能够在疾病发生之前在生命早期常规鉴定基因携带者,从而对这些患者及时进行预防性甲状腺切除术。本报告包括我们在1994年至2005年期间对土耳其MEN 2家族以及诊断和治疗的散发性甲状腺髓样癌患者的临床和分子经验。